复发或难治性血液恶性肿瘤的临床试验
总计8575个结果
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Blueprint Medicines Corporation完全的肥大细胞白血病 | 侵袭性系统性肥大细胞增多症 | 系统性肥大细胞增多症相关血液学非肥大细胞病 | 复发或难治性髓系恶性肿瘤美国, 英国
-
Gilead SciencesCalifornia Institute for Regenerative Medicine (CIRM)完全的
-
University College, London暂停
-
Amsterdam UMC, location VUmcZonMw: The Netherlands Organisation for Health Research and Development; FondsNutsOhra完全的
-
Julie-An M. TalanoMiltenyi Biotec, Inc.主动,不招人
-
Seoul National University HospitalMinistry of Health, Republic of Korea; The Korea Health Technology R&D Project through the Korea...未知
-
Yale UniversityHospira, now a wholly owned subsidiary of Pfizer完全的
-
Sidney Kimmel Cancer Center at Thomas Jefferson...完全的
-
Baylor College of MedicineThe Methodist Hospital Research Institute终止
-
H. Lee Moffitt Cancer Center and Research Institute完全的
-
Catholic University of the Sacred HeartPagano L, Aversa F, Locatelli F, Nosari A,Rossi G, Viale P完全的
-
Loyola UniversityGamida Cell ltd完全的
-
St. Jude Children's Research HospitalGenzyme, a Sanofi Company完全的
-
Dana-Farber Cancer InstituteMiltenyi Biomedicine GmbH完全的
-
Indiana University School of MedicineGenzyme, a Sanofi Company完全的
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Amgen完全的
-
Bellicum Pharmaceuticals撤销骨髓增生异常综合征 | 白血病 | 多发性骨髓瘤 | 淋巴瘤 | 其他高危血液系统恶性肿瘤
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna招聘中
-
Duke UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)招聘中
-
Memorial Sloan Kettering Cancer Center完全的
-
Maisonneuve-Rosemont HospitalCanadian Institutes of Health Research (CIHR); Hopital de l'Enfant-Jesus; St. Justine's Hospital; Canadian Cancer Society (CCS) 和其他合作者完全的
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Robert Wood Johnson Foundation; American Society of Hematology招聘中